CERTARA INC. - COMMON STOCK

Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation

04 янв 2023 06:31:24 Источник Nasdaq GlobeNewswire

Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors

08 дек 2022 15:30:00 Источник Nasdaq GlobeNewswire

Certara Reports Third Quarter 2022 Financial Results

07 ноя 2022 15:15:01 Источник Nasdaq GlobeNewswire

Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase

07 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

02 ноя 2022 16:00:00 Источник Nasdaq GlobeNewswire

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions

19 окт 2022 07:00:02 Источник Nasdaq GlobeNewswire

Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022

13 окт 2022 06:45:00 Источник Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

31 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire

Certara Announces Secondary Offering

11 авг 2022 15:38:42 Источник Nasdaq GlobeNewswire

Certara Reports Second Quarter 2022 Financial Results

09 авг 2022 15:15:01 Источник Nasdaq GlobeNewswire

Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module

05 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire

Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies

28 июл 2022 07:00:01 Источник Nasdaq GlobeNewswire

Certara Appoints Rosemary Crane as New Independent Board Member

25 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire

Certara Appoints Eran Broshy as New Independent Board Member

13 июл 2022 07:00:01 Источник Nasdaq GlobeNewswire

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

12 июл 2022 07:00:01 Источник Nasdaq GlobeNewswire

Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development

28 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire

Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics

21 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire

Certara Reports First Quarter 2022 Financial Results

05 май 2022 15:15:00 Источник Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

03 май 2022 15:30:00 Источник Nasdaq GlobeNewswire

Certara to Report First Quarter 2022 Financial Results on May 5th, 2022

20 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire